Literature DB >> 6405629

Relation of gastric acid and pepsin secretion to serum gastrin levels in dogs given bombesin and gastrin-17.

B I Hirschowitz, E Molina.   

Abstract

To quantitate bombesin stimulation of gastric acid and pepsin via release of gastrin, five gastric fistula dogs were given graded doses (60-1,250 pmol X kg-1 X h-1) of bombesin tetradecapeptide and 40-2,000 pmol X kg-1 X h-1 of synthetic gastrin-17 (G-17). Acid and pepsin output and serum gastrin were proportional to the dose of stimulant. The half-maximal dose of bombesin for gastrin release was 200 pmol X kg-1 X h-1. Bombesin-stimulated acid secretion related to serum gastrin concentrations was congruent with the G-17 curve, but with a maximum of only 62% of the G-17 maximum before declining by 27% despite higher serum gastrin levels. This suggested that bombesin stimulates acid secretion only via gastrin release and inhibits at higher doses by releasing another inhibitory peptide, most likely somatostatin, which is also released by bombesin. The same mechanism could apply to supramaximal inhibition of acid and pepsin seen with high doses of G-17. Because the pepsin curve related to serum gastrin was to the left of the G-17 curve, we concluded that another secretagogue released by bombesin acts synergistically with gastrin on pepsin secretion. Therefore, bombesin stimulates gastric secretion through gastrin release, but its effects are modified by peptides coreleased to a) increase pepsin output at low doses and b) limit the output of acid and pepsin to 50-60% of the G-17 maximum.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6405629     DOI: 10.1152/ajpgi.1983.244.5.G546

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  9 in total

1.  Expression of the human insulin gene in the gastric G cells of transgenic mice.

Authors:  E Zhukova; A Afshar; J Ko; P Popper; T Pham; C Sternini; J H Walsh
Journal:  Transgenic Res       Date:  2001-08       Impact factor: 2.788

2.  Low circulating levels of gastrin-17 in patients with Barrett's esophagus.

Authors:  Pentti Sipponen; Matti Vauhkonen; Timo Helske; Ilpo Kaariainen; Matti Harkonen
Journal:  World J Gastroenterol       Date:  2005-10-14       Impact factor: 5.742

3.  Paradoxical effects of gastrin releasing peptide on gastrin release and gastric secretion in the rat.

Authors:  A Takagi; M Moriga; H Narusawa; H Uchino; M Aono
Journal:  Gastroenterol Jpn       Date:  1986-12

4.  Changes of Gastric Secretion after Bolus and Slow Intravenous Administration of Bombesin and Neurotensin.

Authors:  Konstantinos Tsalis; Orestis Ioannidis; Chrysovalantis Mariorakis; Panagiotis Christidis; Lydia Loutzidou; Ioannis Mantzoros; Efstathios Kotidis; Manousos George Pramateftakis; Nikolaos Ouzounidis; Stamatios Aggelopoulos
Journal:  Maedica (Bucur)       Date:  2021-12

Review 5.  The production and role of gastrin-17 and gastrin-17-gly in gastrointestinal cancers.

Authors:  Jeffrey Copps; Richard F Murphy; Sándor Lovas
Journal:  Protein Pept Lett       Date:  2009       Impact factor: 1.890

6.  Effects of anti-GRP gamma-globulin on gastrin release and gastric secretion in the rat: evidence for the physiologic role of endogenous GRP in the regulation of gastric function.

Authors:  A Takagi; M Moriga; H Uchino; M Aono
Journal:  Gastroenterol Jpn       Date:  1987-06

7.  Distribution of gastrin-releasing peptide (GRP)-like immunoreactivity in the rat.

Authors:  A Takagi; M Moriga; H Uchino; M Aono
Journal:  Gastroenterol Jpn       Date:  1987-04

8.  Bombesin and G-17 dose responses in duodenal ulcer and controls.

Authors:  B I Hirschowitz; L O Tim; C A Helman; E Molina
Journal:  Dig Dis Sci       Date:  1985-11       Impact factor: 3.199

Review 9.  Helicobacter pylori and hormones.

Authors:  J Calam
Journal:  Yale J Biol Med       Date:  1996 Jan-Feb
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.